reference/27576736

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27576736

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Review
endingPage	277
issn	1040-8746
issueIdentifier	3
pageRange	272-277
publicationName	Current Opinion in Oncology
startingPage	272
bibliographicCitation	Courtney KD, Taplin ME. The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer. Curr Opin Oncol. 2012 May;24(3):272–7. doi: 10.1097/cco.0b013e328351059d. PMID: 22327837.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5f85d801dcf389a6acae1e1fc4af2c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a571281b6bf572234d4fb6288f132654
date	201205
identifier	https://pubmed.ncbi.nlm.nih.gov/22327837 https://doi.org/10.1097/cco.0b013e328351059d
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1063 https://portal.issn.org/resource/ISSN/1040-8746
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0001108 http://id.nlm.nih.gov/mesh/M0001106 http://id.nlm.nih.gov/mesh/M0237229 http://id.nlm.nih.gov/mesh/M0001114 http://id.nlm.nih.gov/mesh/M0484955 http://id.nlm.nih.gov/mesh/M0002348 http://id.nlm.nih.gov/mesh/M0016576 http://id.nlm.nih.gov/mesh/M0001115 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0573548 http://id.nlm.nih.gov/mesh/M0577955 http://id.nlm.nih.gov/mesh/M0021357 http://id.nlm.nih.gov/mesh/M0018556 http://id.nlm.nih.gov/mesh/M0020523
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D000728Q000378 http://id.nlm.nih.gov/mesh/D000726Q000494 http://id.nlm.nih.gov/mesh/D009376Q000188 http://id.nlm.nih.gov/mesh/D019008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009570 http://id.nlm.nih.gov/mesh/D010669Q000494 http://id.nlm.nih.gov/mesh/D011944Q000378 http://id.nlm.nih.gov/mesh/D000728Q000096 http://id.nlm.nih.gov/mesh/D002986 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D010669Q000031 http://id.nlm.nih.gov/mesh/D001562Q000494 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D000736 http://id.nlm.nih.gov/mesh/D013867Q000494 http://id.nlm.nih.gov/mesh/D013254Q000037 http://id.nlm.nih.gov/mesh/D000726Q000008 http://id.nlm.nih.gov/mesh/D001549 http://id.nlm.nih.gov/mesh/D000737Q000494 http://id.nlm.nih.gov/mesh/D000730Q000494 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9c2eb41267934654ad86d8795624a05b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_005ef34c8ba989d84eb20cdc3a19dd7c http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9821849 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15951529

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129345975 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128029089

Total number of triples: 73.